Developing a new ink for better endoscopic marking in colorectal cancer
Official title: Next-generation Tissue-Adhesive Endoscopic Tattoo Ink
Funded at Endotat Biotechnologies LLC · NIH-11069963 · Data updated 2026-11-12
This study is testing a new type of tattoo ink that helps doctors mark areas in the gut more accurately during procedures, which is really important for keeping an eye on and treating colorectal cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Endotat Biotechnologies LLC NIH-funded |
| Lab location | 1 site (Phoenix, United States) |
| Project start | September 23, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $343,000 |
| NIH project number | 1R41DK142564-01 |
| Project ID | NIH-11069963 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals undergoing colonoscopies or upper GI endoscopies, particularly those with lesions that require precise marking.
✕Less likely to help
Patients who do not require endoscopic procedures or those without colorectal lesions may not benefit from this research.
What this research studies
This research focuses on creating a next-generation tissue adhesive tattoo ink designed for use during endoscopic procedures. The new ink aims to improve the precision of marking lesions in the gastrointestinal tract, which is crucial for monitoring and treating colorectal cancer. By ensuring that the ink remains localized without diffusing into surrounding tissues, it seeks to enhance the effectiveness of follow-up procedures and surgeries. The project will involve testing the ink's performance in comparison to existing commercial options, particularly in terms of tissue retention and inflammatory response.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and effective monitoring of colorectal cancer, potentially improving patient outcomes and survival rates.
How similar studies have gone: Previous research has shown promise in developing improved endoscopic marking techniques, but this specific approach with tissue adhesive inks is relatively novel.
Where this research is happening
-
Endotat Biotechnologies LLC
Phoenix, United States Active
Researchers
- Principal investigator: Rege, Kaushal — Endotat Biotechnologies LLC
- Study coordinator: Rege, Kaushal
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.